2019 annual financial data
Kymera Therapeutics 2019 Net margin
Direct answer
Net margin was -1,407.36%.
Operating income was -42,205,000 USD and net income was -41,292,000 USD.
Operating cash flow was 17,905,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,934,000 USD
- Operating income
- -42,205,000 USD
- Net income
- -41,292,000 USD
- Operating cash flow
- 17,905,000 USD